Healthcare - Biotechnology - NASDAQ - US
$ 0.519
-12.1 %
$ 32.1 M
Market Cap
-0.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
22.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Passage Bio, Inc.
PASG has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PASG
EBIT FORECAST
EBIT Forecast Chart PASG
NET INCOME FORECAST
Net Income Chart PASG